GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
- Citation:
- Leukemia vol 28 (6) 1252-1258
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 780
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, P50 CA140158, U10 CA180861, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, U10 CA180882, P30 CA016058, CA77658, CA129657, CA114725, T32 CA009338, CA31946
- Corr. Author:
- Authors:
- Susan P. Whitman Jessica Kohlschmidt Kati Maharry Stefano Volinia Krzysztof Mrózek Deedra Nicolet Sebastian Schwind Heiko Becker Klaus H. Metzeler Jason H. Mendler Ann-Kathrin Eisfeld Andrew J. Carroll Bayard L. Powell Thomas H. Carter Maria R. Baer Jonathan E. Kolitz Il-Kyoo Park Richard M. Stone Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8525, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9720, CALGB-10201, CALGB-19808
- Phases:
- 1, 3
- Keywords:
- GAS6, acute myeloid leukemia, prognosis